Sort
21,453 grants matching “tuberculosis”
The roles of genes critical for growth in vitro
$684,551Dirk Schnappinger · Harvard School Of Public Health · U19 · FY2013 · AI
High-throughput identification of common CD8+ T cell responses to SIV and M. tuberculosis in rhesus macaques
$684,547David H Oconnor · University Of Wisconsin-Madison · R24 · FY2019 · OD
Epidemiology of multidrug-resistant tuberculosis in Peru
$684,489Mercedes C Becerra · Harvard Medical School · R01 · FY2006 · AI
Identifying Common T Cell Responses to Major Pathogens in Rhesus Macaques
$684,375David H Oconnor · University Of Wisconsin-Madison · R24 · FY2014 · OD
Hollow Fiber Infection Model to Delineate Combination Drug Interaction for Different MTB Metabolic Populations and using Different Pharmacokinetic Profiles
$684,266George Louis Drusano · University Of Florida · P01 · FY2018 · AI
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS
$684,119Texas Agrilife Research · P01 · FY2001 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
$683,851Diane V Havlir · University Of California, San Francisco · R01 · FY2019 · AI
High-throughput identification of common CD8+ T cell responses to SIV and M. tuberculosis in rhesus macaques
$683,815David H Oconnor · University Of Wisconsin-Madison · R24 · FY2020 · OD
A TB Vaccine for AIDS Patients
$683,780Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2010 · AI
Task 6: Technical Support for Tuberculosis Therapeutics
$683,747Jon Carl Mirsalis · Sri International · N01 · FY2017 · AI
Studies of Inherited Causes of Fungal Susceptability
$683,551Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Administrative Core
$683,546Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2012 · AI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
$683,274David M. Lewinsohn · Oregon Health & Science University · R01 · FY2021 · AI
The Impact of Tolerance in the Newborn on Lentiviral Infection
$683,272Joseph M McCune · University Of California, San Francisco · R01 · FY2013 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
$683,177Diane V Havlir · University Of California, San Francisco · R01 · FY2022 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis
$683,161Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
INDIANA STATE DEPT OF HEALTH TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE
$683,131Sarah Burkholder · Indiana State Department Of Health · U52 · FY2012 · PS
Administrative Core
$683,001Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2010 · AI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
$682,980Susan E Dorman · Johns Hopkins University · R01 · FY2012 · AI
Longitudinal Study of HIV and Aging in Brazil
$682,853Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2021 · AG
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
$682,830Scott K Heysell · University Of Virginia · U01 · FY2020 · AI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$682,769Richard S Garfein · University Of California, San Diego · R01 · FY2014 · DA
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics
$682,642Michael R Wilson · University Of California, San Francisco · R01 · FY2021 · AI
INDIANA STATE DEPT OF HEALTH TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE
$682,466Sarah Burkholder · Indiana State Department Of Health · U52 · FY2011 · PS
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity
$682,368Jonathan E Golub · Johns Hopkins University · R01 · FY2023 · AI